共 34 条
- [31] A randomized, open-label study to compare the efficacy and safety of two different sirolimus (SRL) regimens with tacrolimus (TAC) plus mycophenolate mofetil (MMF) in de novo renal allograft recipients: Preliminary 2-year efficacy results from the ORION trial AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 254 - 254
- [32] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with tacrolimus (TAC) plus mycophenolate mofetil (MMF) in De Novo renal allograft recipients:: Preliminary 2-year safety results from the ORION trial AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 582 - 582
- [33] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SR-L) regimens with a tacrolimus (Tac) and mycophenolate mofetil regimen (MMF) in de novo renal allograft recipients: Acute rejection and graft survival results from the ORION study. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 160 - 160
- [34] Low incidence of acute graft-vs.-host disease (GVHD) using tacrolimus (TAC) and mycophenolate mofetil (MMF) after matched sibling donor (MSD) non-myeloablative stem-cell transplants (NST) conditioned with fludarabine (FLU) and low-dose total body irradiation (TBI). BLOOD, 2004, 104 (11) : 349B - 349B